These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34801000)

  • 1. Model difference in the effect of cilostazol on the development of experimental pulmonary hypertension in rats.
    Ito T; Zhang E; Omori A; Kabwe J; Kawai M; Maruyama J; Okada A; Yokochi A; Sawada H; Mitani Y; Maruyama K
    BMC Pulm Med; 2021 Nov; 21(1):377. PubMed ID: 34801000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of thrombomodulin on the development of monocrotaline-induced pulmonary hypertension.
    Yamada Y; Maruyama J; Zhang E; Okada A; Yokochi A; Sawada H; Mitani Y; Hayashi T; Suzuki K; Maruyama K
    J Anesth; 2014 Feb; 28(1):26-33. PubMed ID: 23817901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung damage created by high tidal volume ventilation in rats with monocrotaline-induced pulmonary hypertension.
    Kawai M; Zhang E; Kabwe JC; Okada A; Maruyama J; Sawada H; Maruyama K
    BMC Pulm Med; 2022 Mar; 22(1):78. PubMed ID: 35247989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension.
    Partovian C; Adnot S; Eddahibi S; Teiger E; Levame M; Dreyfus P; Raffestin B; Frelin C
    Am J Physiol; 1998 Dec; 275(6):H1948-56. PubMed ID: 9843792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats.
    Tofovic SP; Salah EM; Mady HH; Jackson EK; Melhem MF
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):430-7. PubMed ID: 16160593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone inhibits vascular remodeling and attenuates monocrotaline-induced pulmonary hypertension in estrogen-deficient rats.
    Tofovic PS; Zhang X; Petrusevska G
    Prilozi; 2009 Jul; 30(1):25-44. PubMed ID: 19736529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
    Guerard P; Rakotoniaina Z; Goirand F; Rochette L; Dumas M; Lirussi F; Bardou M
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of inhibition of nitric oxide production in monocrotaline-induced pulmonary hypertension.
    Mathew R; Gloster ES; Sundararajan T; Thompson CI; Zeballos GA; Gewitz MH
    J Appl Physiol (1985); 1997 May; 82(5):1493-8. PubMed ID: 9134898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cilostazol therapy attenuates monocrotaline-induced pulmonary arterial hypertension in rat model.
    Chang LT; Sun CK; Sheu JJ; Chiang CH; Youssef AA; Lee FY; Wu CJ; Yip HK
    Circ J; 2008 May; 72(5):825-31. PubMed ID: 18441466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged inhaled NO attenuates hypoxic, but not monocrotaline-induced, pulmonary vascular remodeling in rats.
    Horstman DJ; Frank DU; Rich GF
    Anesth Analg; 1998 Jan; 86(1):74-81. PubMed ID: 9428855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of GATA6 gene in lung tissue of rat with pulmonary hypertension].
    Liu B; Liu HM; Yu L; Sun XJ; Wei L; Wang XM; Zhou TF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):864-7, 875. PubMed ID: 17236581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of sesamin on pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary hypertension].
    Li XW; Gao YX; Li S; Yang JR
    Zhongguo Zhong Yao Za Zhi; 2015 Apr; 40(7):1355-61. PubMed ID: 26281561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tanshinone IIA sulfonate upregulated pulmonary artery smooth muscle peroxisome proliferator-activated receptor γ expression in monocrotaline induced pulmonary hypertension rat].
    Jiang Q; Chen Y; Chen X; Zhang J; Lu W; Wang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 May; 37(5):360-4. PubMed ID: 25011512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
    Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early combined treatment with cilostazol and bone marrow-derived endothelial progenitor cells markedly attenuates pulmonary arterial hypertension in rats.
    Sun CK; Lee FY; Sheu JJ; Yuen CM; Chua S; Chung SY; Chai HT; Chen YT; Kao YH; Chang LT; Yip HK
    J Pharmacol Exp Ther; 2009 Sep; 330(3):718-26. PubMed ID: 19528354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired vasoconstriction and nitric oxide-mediated relaxation in pulmonary arteries of hypoxia- and monocrotaline-induced pulmonary hypertensive rats.
    Mam V; Tanbe AF; Vitali SH; Arons E; Christou HA; Khalil RA
    J Pharmacol Exp Ther; 2010 Feb; 332(2):455-62. PubMed ID: 19915069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3,7-Bis(2-hydroxyethyl)icaritin, a potent inhibitor of phosphodiesterase-5, prevents monocrotaline-induced pulmonary arterial hypertension via NO/cGMP activation in rats.
    Lan TH; Chen XL; Wu YS; Qiu HL; Li JZ; Ruan XM; Xu DP; Lin DQ
    Eur J Pharmacol; 2018 Jun; 829():102-111. PubMed ID: 29665366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.
    Voelkel NF; Tuder RM; Bridges J; Arend WP
    Am J Respir Cell Mol Biol; 1994 Dec; 11(6):664-75. PubMed ID: 7946395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarpogrelate hydrochloride, a serotonin 5HT2A receptor antagonist, ameliorates the development of chronic hypoxic pulmonary hypertension in rats.
    Zhang E; Maruyama J; Yokochi A; Mitani Y; Sawada H; Nishikawa M; Ma N; Maruyama K
    J Anesth; 2015 Oct; 29(5):715-23. PubMed ID: 25931318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.